Cargando…

Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria

Endothelial nitric oxide synthase (eNOS) deficiency exacerbates proteinuria and renal injury in several glomerular diseases, but the underlying mechanism is not fully understood. We recently showed that heparanase is essential for the development of experimental diabetic nephropathy and glomerulonep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garsen, Marjolein, Rops, Angelique L., Li, Jinhua, van Beneden, Katrien, van den Branden, Christiane, Berden, Jo HM, Rabelink, Ton J., van der Vlag, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978400/ https://www.ncbi.nlm.nih.gov/pubmed/27505185 http://dx.doi.org/10.1371/journal.pone.0160894

Ejemplares similares

Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2023)

Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
por: Buijsers, Baranca, et al.
Publicado: (2023)

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012)

Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis
por: Maciej-Hulme, Marissa L., et al.
Publicado: (2023)

Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis
por: van Gemst, Jasper J., et al.
Publicado: (2021)

Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains
por: van Gemst, J. J., et al.
Publicado: (2018)

Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy
por: Boels, Margien G. S., et al.
Publicado: (2017)

HDAC inhibitors in experimental liver and kidney fibrosis
por: Van Beneden, Katrien, et al.
Publicado: (2013)

Elevated Urine Heparanase Levels Are Associated with Proteinuria and Decreased Renal Allograft Function
por: Shafat, Itay, et al.
Publicado: (2012)

Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study
por: van der Velden, Anouk I M, et al.
Publicado: (2022)

Characterization of anticoagulant heparinoids by immunoprofiling
por: Wijnhoven, Tessa J., et al.
Publicado: (2007)

RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues
por: van Gemst, Jasper J., et al.
Publicado: (2016)

Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury
por: ‘t Hart, Daan, et al.
Publicado: (2021)

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology
por: Lensen, Joost F. M., et al.
Publicado: (2015)

Increased Plasma Heparanase Activity in COVID-19 Patients
por: Buijsers, Baranca, et al.
Publicado: (2020)

Endothelial nitric oxide synthase deficiency and inducible nitric oxide synthase inhibition in the setting of septic cardiomyopathy
por: Sandt, A Van de, et al.
Publicado: (2009)

Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma Leakage
por: Buijsers, Baranca, et al.
Publicado: (2021)

Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study
por: Drost, Carolin Christina, et al.
Publicado: (2022)

Role of interferon regulatory factor 1 in induction of nitric oxide synthase
Publicado: (1994)

Role of syndecan-1 in the interaction between dendritic cells and T cells
por: Kouwenberg, M., et al.
Publicado: (2020)

Neuronal Nitric Oxide Synthase Induction in the Antitumorigenic and Neurotoxic Effects of 2-Methoxyestradiol
por: Gorska, Magdalena, et al.
Publicado: (2014)

Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis
por: Boehm, Mario, et al.
Publicado: (2022)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

A Decade of Marketing Authorization Applications of Anticancer Drugs in the European Union: An Analysis of Procedural Timelines
por: Garsen, Marjolein, et al.
Publicado: (2021)

Class II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29
por: Mannaerts, Inge, et al.
Publicado: (2013)

Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide–deficient rats
por: Girardi, José Marcos, et al.
Publicado: (2011)

Heparanase and Autoimmune Diabetes
por: Simeonovic, Charmaine J., et al.
Publicado: (2013)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

Healthy Volunteer Studies in the Development of Anticancer Drugs with Genotoxic Findings
por: Omes-Smit, Grace, et al.
Publicado: (2021)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Adjustments in Food Choices and Physical Activity during Lockdown by Flemish Adults
por: Mertens, Evelien, et al.
Publicado: (2021)

Identification of Free Nitric Oxide Radicals in Rat Bone Marrow: Implications for Progenitor Cell Mobilization in Hypertension
por: Aleksinskaya, Marina A., et al.
Publicado: (2013)

Evidence that simvastatin prevents induction of nitric oxide synthase by LPS in the porcine isolated coronary artery
por: Al-Shalmani, S, et al.
Publicado: (2009)

Activation of macrophage nuclear factor-κB and induction of inducible nitric oxide synthase by LPS
por: Li, Ying-Hua, et al.
Publicado: (2002)

Mammalian heparanase: what is the message?
por: Vreys, Veronique, et al.
Publicado: (2007)

Heparanase and Coagulation–New Insights
por: Nadir, Yona
Publicado: (2014)

Impact of heparanase on renal fibrosis
por: Masola, Valentina, et al.
Publicado: (2015)

Heparanase inhibitors restrain mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2018)

Heparanase Modulates Chromatin Accessibility
por: Li, Honglian, et al.
Publicado: (2023)

Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0j3foa2led1cj0qu3sln74lp3n